CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+1.91%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.7B
AUM Growth
+$98M
(+0.67%)
Cap. Flow
+$48.4M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
956
New
63
Increased
332
Reduced
303
Closed
69
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$54.5M |
| 2 |
AstraZeneca
AZN
|
$46.3M |
| 3 |
Autodesk
ADSK
|
$40.5M |
| 4 |
Mercado Libre
MELI
|
$39.4M |
| 5 |
Amazon
AMZN
|
$31.1M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$92.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$85.8M |
| 3 |
Alibaba
BABA
|
$60.1M |
| 4 |
Merck
MRK
|
$49.2M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
$48.5M |
Sector Composition
| 1 | Healthcare | 32.1% |
| 2 | Technology | 24.54% |
| 3 | Financials | 9.08% |
| 4 | Communication Services | 8.24% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Canadian National Railway
CNI
$60.3B
| $4.79M | 0.03% |
41,373
-565
| -1% | -$65.5K |
|
402
ResMed
RMD
$40.6B
| $4.79M | 0.03% |
18,176
-731
| -4% | -$193K |
|
403
CDW
CDW
$22.2B
| $4.75M | 0.03% |
26,090
+3,384
| +15% | +$616K |
|
404
American Eagle Outfitters
AEO
$3.26B
| $4.72M | 0.03% |
182,777
-6,483
| -3% | -$167K |
|
405
Revvity
RVTY
$10.1B
| $4.71M | 0.03% |
27,153
-1,378
| -5% | -$239K |
|
406
Dow Inc
DOW
$17.4B
| $4.7M | 0.03% |
81,691
-1,609
| -2% | -$92.6K |
|
407
Emcor
EME
$28B
| $4.63M | 0.03% |
40,122
+14,884
| +59% | +$1.72M |
|
|
BLDP
408
Ballard Power Systems
BLDP
$598M
| $4.59M | 0.03% |
326,505
+102,409
| +46% | +$1.44M |
|
409
Acadia Pharmaceuticals
ACAD
$4.26B
| $4.58M | 0.03% |
275,560
| – | – |
|
410
Restaurant Brands International
QSR
$20.7B
| $4.56M | 0.03% |
74,389
-1,551
| -2% | -$95K |
|
411
KKR & Co
KKR
$121B
| $4.54M | 0.03% |
74,633
+25,859
| +53% | +$1.57M |
|
412
Globus Medical
GMED
$8.18B
| $4.52M | 0.03% |
59,000
+24,000
| +69% | +$1.84M |
|
413
Ultragenyx Pharmaceutical
RARE
$3.07B
| $4.46M | 0.03% |
49,480
| – | – |
|
414
Northern Trust
NTRS
$24.3B
| $4.4M | 0.03% |
40,801
-7,020
| -15% | -$757K |
|
415
Martin Marietta Materials
MLM
$37.5B
| $4.35M | 0.03% |
12,724
+1,511
| +13% | +$516K |
|
416
Tandem Diabetes Care
TNDM
$850M
| $4.25M | 0.03% |
35,587
-38,000
| -52% | -$4.54M |
|
417
MetLife
MET
$52.9B
| $4.24M | 0.03% |
68,645
-68,043
| -50% | -$4.2M |
|
418
Sony
SONY
$165B
| $4.2M | 0.03% |
189,935
+38,235
| +25% | +$845K |
|
419
Kimberly-Clark
KMB
$43.1B
| $4.19M | 0.03% |
31,651
-5,178
| -14% | -$686K |
|
420
Dominion Energy
D
$49.7B
| $4.18M | 0.03% |
57,300
| – | – |
|
421
Karyopharm Therapeutics
KPTI
$57.2M
| $4.18M | 0.03% |
47,845
| – | – |
|
422
Blackstone
BX
$133B
| $4.16M | 0.03% |
35,743
+1,743
| +5% | +$203K |
|
423
T-Mobile US
TMUS
$284B
| $4.13M | 0.03% |
32,324
-827
| -2% | -$106K |
|
424
iShares MSCI Canada ETF
EWC
$3.24B
| $4.11M | 0.03% |
113,314
| – | – |
|
425
Peloton Interactive
PTON
$3.27B
| $4.09M | 0.03% |
46,936
+2,129
| +5% | +$185K |
|